What's Happening?
A new report by Deloitte reveals significant challenges and opportunities in the diagnostics sector as it shifts towards a consumer-driven model. The report highlights that 62% of diagnostics manufacturer executives believe future growth depends on adopting
a business-to-business-to-consumer (B2B2C) operational model. However, there is a strategic disconnect between manufacturers and healthcare providers. While providers identify test ordering as a major friction point, manufacturers focus on results interpretation. The report also notes that 74% of healthcare providers have unintegrated backend systems, posing a hurdle to interoperability. As consumers increasingly adopt home diagnostics and wearable health tools, traditional healthcare providers face pressure to deliver personalized clinical experiences or risk losing market share to tech-savvy entrants.
Why It's Important?
The shift towards a consumer-driven diagnostics model has significant implications for the healthcare industry. Manufacturers and providers must adapt to meet the growing demand for personalized and efficient healthcare solutions. The report underscores the need for manufacturers to integrate AI and improve interoperability to enhance consumer experiences. This transition could lead to more efficient healthcare delivery, reduced costs, and improved patient outcomes. However, the disconnect between manufacturers and providers poses a risk to successful implementation. Bridging this gap is crucial for manufacturers to remain competitive and for providers to retain their market share in a rapidly evolving landscape.
What's Next?
To address these challenges, diagnostics manufacturers may need to re-engineer their engagement strategies with healthcare providers. This could involve shifting focus from procurement relationships to clinical stakeholders who influence product adoption. Additionally, manufacturers might prioritize integrating AI into electronic health record (EHR) workflows to enhance data interoperability. As consumer-initiated testing becomes more prevalent, providers and manufacturers will need to collaborate closely to ensure seamless integration of new technologies. The success of this transition will depend on the ability of stakeholders to align their strategies and address the identified disconnects.
